Regulation of Kv1.3 during fas-induced apoptosis

Cellular Physiology and Biochemistry

Volumn 7, Issue 3-4, 1997, Pages 148-158

  Szabö, Ildikö ^a   Gulbins, Erich ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Apo 1; Apoptosis; Ceramide; Fas; Kv1.3; Lymphocyte; Src like tyrosine kinase; Voltage gated potassium channel

Indexed keywords

CERAMIDE; FAS ANTIGEN; POTASSIUM CHANNEL; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

EID: 0030930641     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000154870     Document Type: Article

References (94)

1. Kroemer G. Pcitit P, Zamzami N, Vayssierc JL. Mignotte B: The bio-chemistry of programmed cell death. FASEBJ 1995:9:1277.
2. Sleller H: Mechanisms and genes of cellular suicide. Science 1995:267: 1445.
3. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995:267:1456.
4. Singer GG. Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994:1:365.
5. Watanaba-Fukunaga R. Brannan Cl, Itoh N. Yonchara S, Copeland NG, Jenkins NA. Nagata S: The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J Immunol 1992:148:1274.
6. Zhou T, Bluethmann H, Eldrige J, Brockhaus M. Berry K. Mount JD: Abnormal thymocyte development and production of autorcactivc T cells in T cell receptor transgenic autoimmune mice. J Immunol 1991: 147:466.
7. Debalin KM. Fahrig-Faissner A. Encnkcl-Stoodt S, Kreu W. Benner A, Krammer PH: High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency vi-rus-1-infected children. Blood 1994: 83:3101.
8. Kobayashi N, Hamamoto Y. Yamamoto N. Ishii A. Yonehara M, Yone-hara S: Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 1990: 87:9620.
9. Minden A. Lin A. Claret FX. Abo A, Karin M: Selective activation of the JNK signalling cascade and c-Jun transcriptional activity by the small GTP-ases and Rac and Cdc42Hs. Cell 1995:81:1147.
10. Wilson DJ. Fortner KA. Lynch DH. Mattingly RR. Macara IG. Posada JA, Budd RC: JNK. But not MAPK. Activation is associated with Fas-mediated apoptosis in human T cells. Eur J Immunol 1996: 26: 989.
11. Gulbins E. Brenner B. Schlottmann K. Welsh J. Hcinle H. Koppenhoefer U, Linderkamp O, Coggeshall KM. Lang F: Fas-induced programmed cell death is mediated by a Ras-regulatcd O;. synthesis. Immunology 1996:89:205
12. Jacobson MD: Reactive oxygen species and programmed cell death. Trends Biochem Sci 1996:21:83.
13. Buttke TM, Sandstrom PA: Redox regulation of programmed cell death in lymphocytes. Immunol Today 1994:15:7.
14. Hirose K. Bongo DL. Oppenheim JJ. Matsushima K: Ovcrcxpression of mitochondrial manganese super-oxide dismutase promotes the survival of tumor cells exposed to interleukin-1. Tumor necrosis factor, selected anticancer drugs and ionizing radiation. FASEBJ 1993:7:361.
15. Takavama S, Sato T. Krajewski S, Kochcl K. Iric S. Millan JA, Reed JC: Cloning and functional analysis of BAG-1: A novel Bcl-2 binding protein with anti-cell death activity. Cell 1995:80:279.
16. Urn HD, Orenstein JM. Wal SM: Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol 1996:156:3469.
17. Ji L. Zhang G. Hirabayashi Y: Tumor necrosis factor alpha increases tyrosine phosphorylation of a 23 kDa nuclear protein in U937 cells through ceramidc signalling pathway. Biochem Biophys Res Commun 1995:215:489.
18. Gulbins E. Szabo I, Baltzer K. Lang F: Ceramide induced inhibition of L-lymphocytc voltage gated potassium channel is mediated by tyrosine kinases. Proc Natl Acad Sci USA 1997:submitted.
19. Ogasawara J, Watanabc-Fukunaga R. Adachi M. Matsuzawa A, Kasu-gai T. Kilamura Y. Itoh N. Suda T. Nagata S: Lethal effect of the anti-Fas antibody in mice. Nature 1993: 364:806.
20. Gulbins E. Szabo I. Lang F: Physiology of Fas induced programmed cell death. Cell Physiol Biochem 1996:6: 361.
21. Schloltmann K, Coggcshall KM: CS95/Fas/Apo-1 -mediated signal transduction. Cell Physiol Biochcm 1996:6:376.
22. Cifone MG. DcMaria R. Roncali P. Rippo MR. Azuma M. Lanier LL. Santoni A. Testi R: Apoptotic signaling through. CD95 (Fas/Apo-I) activates an acidic sphingomyelinase. J Exp Med 1994:180:1547.
23. Gulbins E, Bissonette R. Mahboubi A. Nishioka W. Brunner T. Baier G, Baier-Bitterlich G. Byrd C, Land F. Kolcsnick R. Altman A. Green D: Fas-induced apoptosis is mediated via a ceramide-initiatcd Ras signaling pathway. Immunity 1995:2:341.
24. Cifone MG. Roncaioli P, DcMaria R. Camarda G. Santoni A, Ruberti G, Testi R: Multiple pathways originate at the Fas/Apo-I (CD95) receptor: Sequential involvement of phos-phat idylcholine-spccific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EM BO J 1995:14:5859.
25. Hannun YA: Functions of ccramidc in coordinating cellular responses to stress. Science 1996:274:1855.
26. Gulbins E. Coggeshall KM. Brenner B. Schlottmann K. Linderkamp O. Lang F: Fas-induced apoptosis is mediated by activation of a Ras and Rac protein regulated signaling pathway. J Biol Chem 1997:in press.
27. Gulbins E. Brenner B. Hcrmisson M, Koppenhoefer U. Linderkamp O, Coggeshall KM. Lang F: Ras induces apoptosis by Ras regulated phosphoinositide-3-kinase activation. Mol Cell Biol 1997:submitted.
28. Verheij M. Bose R. Lin XH. Yao B, Jarvis WD, Grant S. Birre MJ. Szabo E. Zon LL Kyriakis JM. Haimo-vitz-Fricdman A, Fuks Z. Kolesnick RN: Requirement for ccramidc initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996:380:75.
29. Eischen CM, Dick CJ, Lcibson PJ: Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 1994; 153:1947.
30. Sato T. Irie S, Kitada S. Reed JC: FAP-I: A protein tyrosine phosphatase that associates with Fas. Science 1995:268:411.
31. Latinis KM. Korctzky GA: Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood 1996:87:871.
32. Schraven B. Peter ME: APO-l(CD95)-mediated apoptosis in Jur-kat cells docs not involve sre kinases or CD45. FF.BS Lett 1995:368:491.
33. Hane M, Lowin B. Peitsch M. Becker K. Tschopp J: Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain. FEBS Lett 1995:373:265.
34. Schlottmann K, Gulbins E, Lau SM. Coggcshall KM: Activation of sre family kinases during Fas induced apoptosis. J Leukocyt Biol 1996:60: 546.
35. Smyth MJ. Perry DK. Zhang J. Poirier GG, Hannun YA. Obeid LM: prICE: A downstream target foreer-amide-induccd apoptosis and for the inhibitory action of Bcl-2. Biochem J 1996:316:25.
36. Martin SJ. O'Brien GA. Nishioka WR. McGahon AJ. Mahboubi A. Saido TC. Green DR: Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem 1995: 270:6425.
37. Miura M. Zhu H. Rotello R, Hart-wieg EA. Yuan J: Induction of apoptosis in fibroblasts by IL-I beta-converting enzyme, a mammalian homolog of the C elegant cell death gene ccd-3. Cell 1993:75:653.
38. Kovacs B. Tsokos GC: Cross-linking of the Fas/APO-l antigen suppresses the CD3-mediated signal transduction events in human T lymphocytes. J Immunol 1995; 155:5543.
39. Cahalan MD. Chandy KG, DeCour-sey TE. Gupta S: A voltage-gated potassium channel in human T lymphocytes. J Physiol 1985:358:197.
40. +channel gene. Proc Natl Acad Sci USA 1990:87:9411.
41. Douglass J, Osborne PB, Cai YC. Wilkinson M, Christie MJ. Adel-man JP: Characterization and functional expression of a rat genomic DNA clone encoding a lymphocyte potassium channel. J Immunol 1990; 144:4841.
42. Pongs O: Molecular biology of voltage-dependent potassium channels. Physiol Rev 1992:72:S69.
43. +channels in primary human T lymphocytes. J Gen Physiol 1992:99:771.
44. Lewis RS. Cahalan MD: Ion channels and signal transduction in lymphocytes. Annu Rev Physiol 1990: 52:415.
45. Chandy KG. DcCoursev TE. Cahalan MD. McLaughlin C. Gupta S: Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med 1984; 160:369.
46. Lin CS. Boltz RC. Blake JT. Nguyen M. Talento A. Fischer PA, Springer MS. Sigal NH. Slaughter RS. Garcia ML. Kaczorowski GJ, Koo GC: Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J Exp Med 1993: 177:637.
47. Leonard RJ. Garcia ML. Slaughter RS. Reuben JP: Selective blockers of voltage-gated K- channels depolarize human T lymphocytes: Mechanism of the antiproliferative effect of charybdotoxin. Proc Natl Acad Sci USA 1992:89:10094.
48. Szabo I. Gulbins E. Apfel H. Zhang X. Barth P. Busch AE. Schlottmann K. Pongs O, Lang F: Tyrosine phosphorylation-dependent suppression of a voltage-gated K‘channel in T lymphocytes upon Fas stimulation. J Biol Chem 1996:271:20465.
49. Garcia-Calco M, Leonard RJ. No-vick J. Stevens SP. Schmalhofcr W, Kaczorowski GJ. Garcia ML: Purification. characterization and biosynthesis of margaloxin, a component of Ceniruroides margaritalus venom that selectively inhibits voltage-de-pendent potassium channels. J Biol Chem 1993:268:18866.
50. +channels in human and murineT lymphocytes. J Gen Physiol 1989: 93:1061.
51. Deckers CL. Lyons AB. Samuel K. Sanderson A. Maddy AH: Alternative pathways of apoptosis induced by méthylprednisolone and valino-ntycin analyzed by How cytometry. Exp Cell Res 1994:208:362.
52. −channels in T lymphocytes: Functional consequences for volume regulation. Proc Natl Acad Sci USA 1993:90:10036.
53. Walev I, Rcske K. Palmer M. Vale-va A. Bhakdi S: Potassium-inhibited processing of IL-l-beta in human monocytes. EMBOJ 1995:14:1607.
54. Ruppcrsberg JP. Stocker M. Pongs O. Heinemann SH. Frank R. Koe-nen M: Regulation of fast of cloned Ikiai channels by casteine oxidation. Nature 1991:352:711.
55. Busch AE. Waldegger S. Herzer T. Raber G. Gulbins E. Takumi T, Mo-riyoshi K. Nakanishi S. LangF: Molecular basis of Isk protein regulation by oxidation or chelation. J Biol Chem 1995:270:3638.
56. Dupral F. Guillemare E, Romcy G. Fink M. Lesage F. Lazdunski M. Honore E: Susceptibility of cloned K' channels to reactive oxygen species. Proc Natl Acad Sci USA 1995: 92:1 1796.
57. +channels in T lymphocytes and Xenopus oocytes. Eur J Physiol Pfliigcrs Arch 1997:433: 626.
58. Levitan IB: Modulation of ion channels by protein tyrosine phosphorylation and dephosphorylation. Ann Rev Physiol 1994:56:193.
59. +channel in Jur-kat T lymphocytes by proicin kinases A and C. J Biol Chem 1992: 267:18270.
60. Busch AE. Varnul MD. North RA. Adelman JP: An amino acid mutation in a potassium channel that prevents inhibition by protein kinascC. Science 1992:255:1705.
61. Covarrubias M, Wei A. Salkoff L. Vyas TB: Elimination of rapid potassium channel inactivation by phosphorylation of the inactivation gate. Neuron 1994:13:1403.
62. +channel inactivation gating by the cAMP-dependent protein kinase. Neuron 1994:12:1097.
63. +channel from human T lymphocytes. FEBS Lett 1992:303:229.
64. Dunlap K: Forskolin prolongs action potential duration and blocks potassium current in embryonic chick sensory neurons. Eur J Physiol Pfliigcrs Arch 1985:403:170.
65. Choquet D. Sarthou P. Prim D. Ca-zenave PA, Korn H: Cyclic AMP modulated potassium channel in murine B cells and their precursors. Science 1987:235:1211.
66. +channel activity in Jurkat cells. Cell Immunol 1990:128:385.
67. +conductance in human T cells. Eur J Physiol Pfliigers Arch 1988:412: 133.
68. Pahapill PA, Schlichter LC: Modulation of potassium channels in intact human T lymphocytes. J Physiol 1992:445:407.
69. Cai YC, Douglass J: In vivo and in vitro phosphorylation of the T lymphocyte type n (Kvl.3) potassium channel. J Biol Chem 1993:268: 23720.
70. +channels are modulated by 5-HTlc receptor activation and independently by PKC. Am J Physiol 1993: 265:CT571.
71. Anderson KL, Anderson G. Michell RH. Jenkinson EJ. Owen JJ: Intracellular signalling pathways involved in the induction of apoptosis in immature thymic T lymphocytes. J Immunol 1996:156:4083.
72. Macckcr HT, Hedjbeli S. Alzona M. Le PT: Comparison of apoptosis signaling through T cell receptors. Fas and calcium ionophore. Exp Cell Res 1996:222:95.
73. Ohkusu K. Isobe K. Hikada H. Nakashima I: Elucidation of the protein kinase C-dcpcndent apoptosis in distinct subsets of T lymphocytes in MRL-lpr/lpr mice. Eur J Immunol 1995:25:3180.
74. Ni R, Tomita Y. Matsuda K. Ichiha-ra A. Ishimura K. Ogasawara J, Na-gata S: Fas-mediated apoptosis in primary cultured mouse hépatocytes. Exp Cell Res 1994:215:332.
75. Huang XY. Morielli AD, Peralta E: Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m I muscarinic acetylcholine receptor. Cell 1993:75: 1145.
76. Wilson GF. Kaczmarek LK: Modeswitching of a voltage-gated cation channel is mediated by a protein kinase A-regulated tyrosine phosphatase. Nature 1993:366:433.
77. Timple LC. Fanil WJ: Modulation of a voltage-activated potassium channel by peptide growth factor receptors. J Ncurosci 1994:14:195.
78. Lev SL. Moreno H. Martinez R. Ca-noli P. Peles E. Musacchio JM, Plowman GD. Rudy B. Sehlcssinger J: Protein tyrosine kinase PYK2 involved in Ca *-induccd regulation of ion channel and MAP kinase functions. Nature 1995:376:737.
79. Holmes TC, Fadool DA, Levitan IB: Tyrosine phosphorylation of the Kvl.3 potassium channel. J Neuro-sci 1996:16:1581.
80. Holmes TC. Fadool DA. Ren R. Levitan IB: Association of sre tyrosine kinase with a human potassium channel mediated by SH3 domain. Science 1996:274:2089.
81. Pawsotl T: Protein modules and signalling networks. Nature 1995:373: 573.
82. Songyang Z. Carraway KL. Eck MJ. Harrison SC, Feldman RA. Moham-madi M. Schlessingcr J, Hubbard SR. Smith DP. Eng C. Lorenzo MJ. Ponder BAJ. Mayer BJ. Cantlcy LC: Catalytic specificity protein-tyrosine kinases is critical for selective signalling. Nature 1995:373:536.
83. Maroney AC. Quercshi SA, Foster DA. Brugge JS: Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells. Oncogene 1992:7:1207.
84. Straus DB. Weiss A: Genetic evidence for the involvement of he lek tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 1992:70:585.
85. Nakamura K, Hori T. Sato N, Sugic K. Kawakami T, Yodoi J: Redox regulation of a sre family protein tyrosine kinase p56!ck in T cells. Oncogene 1993:8:3133.
86. Nagata S. Golstein P: The Fas death factor. Science 1995:267:1449.
87. Kroemer G. Martinez AC: Pharmacological inhibition of programmed lymphocyte death. Immunol Today 1994:15:235.
88. Rues WA. Wuttder F: Heterogeneous expression patterns of mammalian potassium channel genes in developing and adult brain. J Neu-rosci 1992:4:1296.
89. Chvatchko Y, Valera S. Aubry JP, Renno T, Buell G, Bonncfoy JY: The involvement of an ATP-gated ion channel. Pjxi. in thymocyte apoptosis. Immunity 1996:5:275.
90. Bean BP: Pharmacology and electro-physiology of ATP-activatcd ion channels. Trends Pharmacol 1992: 13:87.
91. Zheng LM. Zychlinsky A, Liu CC. Ojcius DM, Young JD: Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol 1991:112:279.
92. Pizzo P. Zanovcllo P. Bronte V. DiVirgilio F: Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane channel. Biochem J 1991:274:139.
93. Gottlieb R, Dosanjh A: Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in Cl27 cells: Possible relevance to cystic fibrosis. Proc Natl Acad Sci USA 1996;93:3587.
94. Bcrridgc MV, Tan AS, McCoy KD. Kansara M. Rudcrt F: CD95 Fas/ Apo-ipinduccd apoptosis results in loss of glucose transporter function. J Immunol 1996:156:4092.